SEIN

Netherlands
Specialized expertise in epilepsy and sleep medicine is provided.

About SEIN

SEIN is a Healthcare company based in Netherlands. Specialized expertise in epilepsy and sleep medicine is provided. It operates on a HealthTech and Professional Services model. Its website sein.nl draws about 57 thousand monthly visits. SEIN offers products and services including Epilepsy Care and Sleep Medicine. Its focus areas include Specialized Medicine and Epilepsy and Sleep Disorders.

Company details

SEIN is established as an expertise center focused on epilepsy and sleep medicine in the Netherlands. Services are provided through outpatient clinics, sleep-wake centers, residential care, day programs, and special education schools. Support is offered to improve the quality of life for individuals affected by epilepsy and sleep disorders. Diagnosis, treatment, and ongoing assistance are tailored to individual needs across multiple sectors of healthcare. Research initiatives are conducted to advance understanding and management of these conditions. Collaboration with specialists ensures comprehensive care and support for patients and their families.

  • Headquarters Netherlands
  • Sectors
    Healthcare
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website sein.nl
Key Metrics

Products & Services of SEIN

SEIN offers a comprehensive portfolio of products and services, including Epilepsy Care and Sleep Medicine.

Epilepsy Care
Healthcare

Specialized care for epilepsy diagnosis and treatment provided.

Sleep Medicine
Healthcare

Diagnosis and treatment for sleep disorders are offered.

Funding Insights of SEIN

  • Total Rounds 1
  • Last Round Grant β€” $239,150
  • First Round $239,150

    (Apr 2023)

  • Investors Count 1

All 1 funding rounds of SEIN with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2023$239,150Grant––
Valuation history

1 investors in total: 1 institutional.

Investors in SEIN

SEIN has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Premium access

Investor details for SEIN

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Web traffic of SEIN

The website of SEIN (sein.nl) receives about 57.3K visits a month.

  • Monthly visits
    57.3K

    ▼ 34.5% vs previous month

Similar websites

Websites whose visitors overlap most with SEIN. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
medapp.nl
100%
20.2K#1,299,857View details
kempenhaeghe.nl
82%
10KView details
kwf.nl
61%
244.1K#210,518View details
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about SEIN

SEIN is headquartered in Netherlands.

SEIN is established as an expertise center focused on epilepsy and sleep medicine in the Netherlands. Services are provided through outpatient clinics, sleep-wake centers, residential care, day programs, and special education schools. Support is offered to improve the quality of life for individuals affected by epilepsy and sleep disorders. Diagnosis, treatment, and ongoing assistance are tailored to individual needs across multiple sectors of healthcare. Research initiatives are conducted to advance understanding and management of these conditions. Collaboration with specialists ensures comprehensive care and support for patients and their families.

SEIN offers Epilepsy Care and Sleep Medicine.

SEIN has 1 investor. Key investors include European Union.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available